1. Academic Validation
  2. Enhanced immunogenicity of a functional enzyme by T cell epitope modification

Enhanced immunogenicity of a functional enzyme by T cell epitope modification

  • BMC Immunol. 2002:3:2. doi: 10.1186/1471-2172-3-2.
Jeanette M Mucha 1 Marcia M Stickler A J Poulose Grant Ganshaw Mae Saldajeno Kathy Collier Manley T Huang Fiona A Harding
Affiliations

Affiliation

  • 1 Department of Immunology, Genencor International, Palo Alto, California 94303, USA. [email protected]
Abstract

Background: T helper epitopes are necessary for the induction of high titers of antigen-specific IgG Antibodies. We are interested in the epitope modification of intact proteins as a method to enhance their immunogenicity for the generation of recombinant protein-based vaccines.

Results: Hartley strain guinea pig T cell epitopes were mapped for two related Bacterial proteases. Two T cell epitopes were found in one of the proteases, while a comparatively reduced immunogenicity protease had no detectable T cell epitopes. A T cell epitope sequence homologous to the immunogenic protease was created in the less immunogenic protease by changing a single amino acid. Proliferative responses to the whole protein parent Enzyme were two-fold higher in splenocyte cultures from variant-immunized Animals. We found that the single amino acid change in the variant resulted in a protein immunogen that induced higher titers of antigen-specific IgG antibody at low doses and at early time points during the immunization protocol. The serum from parent- and variant-immunized guinea pigs cross-reacted at both the protein and the peptide level. Finally, Animals primed to the variant but boosted with the parent Enzyme had higher levels of antigen-specific IgG than Animals immunized with the parent Enzyme alone.

Conclusions: With a single amino acid change we have introduced a T cell epitope into a comparatively low-immunogenic Enzyme and have increased its immunogenicity while retaining the enzyme's original proteolytic function. The ability to immunomodulate proteins while leaving their function intact has important implication for the development of recombinant vaccines and protein-based therapeutics.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-P2573
    99.87%, Chromogenic Substrate